Roles of SAA,CRP and LYMPH# in clinical classification and efficiency evaluation of corona virus disease 2019

doi:10.3969/j.issn.1673-8640.2020.10.009

Abstract

Abstract:

Objective To study the roles of serum amyloid A（SAA）,C-reactive protein（CRP）and the absolute value of lymphocyte（LYMPH#） in clinical classification and efficiency evaluation of corona virus disease 2019（COVID-19）. Methods Totally,45 patients with COVID-19,including 31 cases of light type and 14 cases of severe type,which were all improved and discharged,were enrolled,and 50 suspected patients without severe acute respiratory syndrome coronavirus 2（SARS-CoV-2） infection were enrolled as disease control group. A total of 60 healthy subjects were enrolled as healthy control group. SAA,CRP and LYMPH# were determined. Results In severe type group,SAA,CRP and LYMPH# in light type group,disease control group and healthy control group had statistical significance（P<0.05）. CRP in light type group was lower than that in disease control group（P<0.05）,and there was no statistical significance for SAA and LYMPH# between the 2 groups（P>0.05）. SAA in light type group was higher than that in healthy control group（P<0.05）,and LYMPH# was lower（P<0.05）. There was no statistical significance for CRP between the 2 groups（P>0.05）. Compared with the time of admission,SAA and CRP in COVID-19 group were decreased（P<0.05）,and LYMPH# was increased（P<0.05）. Conclusions SAA,CRP and LYMPH# play roles in clinical classification and efficiency evaluation of COVID-19.

Key words: Serum amyloid A, C-reactive protein, Absolute value of lymphocyte, Corona virus disease 2019

CLC Number:

R446.1

TANG Shengyao, LIU Guosheng, CHU Zhihua, DU Guiyan, ZHOU Shuchu, ZHOU Fawei. Roles of SAA,CRP and LYMPH# in clinical classification and efficiency evaluation of corona virus disease 2019[J]. Laboratory Medicine, 2020, 35(10): 1005-1007.

Figures/Tables 2

References 10

[1]	姚宏武,索继江,杜明梅,等. 新型冠状病毒肺炎流行期间医院感染防控难点与对策[J]. 中华医院感染学杂志,2020,30(6):806-810.
[2]	国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第六版). [EB/OL]. (2020-02-19)[2020-03-01]. .
[3]	钱扬会. 2019新型冠状病毒实验室检测与预防研究[J]. 检验医学与临床,2020,17(10):1457-1459.
[4]	LU R,ZHAO X,LI J,et al.Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding[J]. Lancet,2020,395(10224):565-574.
[5]	REN L L,WANG Y M,WU Z Q,et al.Identification of a novel coronavirus causing severe pneumonia in human:a descriptive study[J]. Chin Med J(Engl),2020,133(9):1015-1024.
[6]	ZHOU P,YANG X,WANG X,et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin[J/OL]. BioRxiv,2020. .
[7]	PIOTTI K C,YANTISS R K,CHEN Z,et al.Serum amyloid A immunohistochemical staining patterns in hepatitis[J]. Histopathology,2016,69(6):937-942.
[8]	LIANG Z,PAN H,WANG X,et al.Histopathological features and viral antigen distribution in the lung of fatal patients with enterovirus 71 infection[J]. Virol Sin,2018,33(3):278-281.
[9]	ELMASHAD G M,ELSAYED H M,OMAR Z A,et al.Evaluation of serum amyloid A protein as a marker in neonatal sepsis[J]. Menoufia Med J,2019,32(3):1094-1098.
[10]	付海卫,孔一名,李小波,等. SAA、CRP和ESR联合检测诊断AECOPD的临床价值[J]. 检验医学,2018,33(7):586-589.

组别	例数	SAA/（mg/L）	CRP/（mg/L）	LYMPH#/（×10⁹/L）
正常对照组	60	4.38±1.50	2.92±1.36	2.26±0.56
疾病对照组	50	77.90±18.31	39.96±14.74	1.23±0.26
COVID-19轻症组	31	96.66±56.88^*	3.43±1.27^#	1.08±0.38^*
COVID-19重症组	14	311.29±44.92^*#△	23.27±8.11^*#△	0.51±0.17^*#△

组别	例数	SAA/（mg/L）	CRP/（mg/L）	LYMPH#/（×10⁹/L）
正常对照组	60	4.38±1.50	2.92±1.36	2.26±0.56
疾病对照组	50	77.90±18.31	39.96±14.74	1.23±0.26
COVID-19轻症组	31	96.66±56.88^*	3.43±1.27^#	1.08±0.38^*
COVID-19重症组	14	311.29±44.92^*#△	23.27±8.11^*#△	0.51±0.17^*#△

项目	例数	SAA/ （mg/L）	CRP/（mg/L）	LYMPH#/（10⁹/L）
入院时	45	163.43±113.57	9.60±10.34	0.90±0.42
出院时	45	10.30±6.20	4.04±3.66	1.55±0.61
t值		9.43	5.29	12.21
P值		0.00	0.00	0.00

项目	例数	SAA/ （mg/L）	CRP/（mg/L）	LYMPH#/（10⁹/L）
入院时	45	163.43±113.57	9.60±10.34	0.90±0.42
出院时	45	10.30±6.20	4.04±3.66	1.55±0.61
t值		9.43	5.29	12.21
P值		0.00	0.00	0.00

[1]	WU Caorong, CUI Wen, TANG Binbin, HE Jingjing, LAI Zhikun. Correlations between the ratio of C-reactive protein to prealbumin and the prognosis of patients with acute heart failure [J]. Laboratory Medicine, 2023, 38(6): 579-583.
[2]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[3]	YUE Caidie, LI Junyan, DING Aijun, XIE Li, ZENG Weikun. Research progress of rapid determination methods for SARS-CoV-2 antigen [J]. Laboratory Medicine, 2023, 38(1): 87-93.
[4]	LI Dongxiu, HUANG Jian. Roles of serum sICAM-1 and hs-CRP levels in monitoring acute viral lower respiratory tract infection in children [J]. Laboratory Medicine, 2022, 37(3): 226-229.
[5]	SONG Yunxiao, TONG Wei, ZHANG Haichen, ZHANG Yinwang, BIAN Xiaobo, ZHANG Linlin, YUAN Wenhua, ZHAO Zhiyun, GE Wen, YAO Tianyue. Correlation of systemic inflammatory markers and fracture occurrence in elderly patients with osteoporosis [J]. Laboratory Medicine, 2022, 37(3): 235-239.
[6]	YAO Hualong. Roles of PTH，CRP，OPG/PYR ratio in elderly patients with osteoporosis [J]. Laboratory Medicine, 2022, 37(12): 1146-1150.
[7]	SUN Jiaqi, JIN Weifeng, LI Ping, CHEN Shuzi, LIN Ping, LI Dan, CHEN Qing, WANG Mengxia, ZHU Yuxin. Influence of heat inactivation of blood samples at 56 ℃ for 30 min on psychiatric drug concentration monitoring [J]. Laboratory Medicine, 2022, 37(12): 1174-1177.
[8]	HE Xuelian, HE Ziyi, LIU Yueyang, YU Yanzhi, ZHANG Siying. Role of line chart model based on peripheral blood-derived inflammation markers in early diagnosis of neonatal septicemia [J]. Laboratory Medicine, 2022, 37(10): 921-927.
[9]	LIU Chunxiao, YI Changlin, WANG Xiaoshan, ZHU Yongzhen, LUO Aner, CHEN Changqiang. Roles of MxA，CRP and WBC count in the differential diagnosis of acute respiratory tract viral and bacterial infections [J]. Laboratory Medicine, 2022, 37(10): 944-947.
[10]	XIONG Zhongbo, WANG Lei, YIN Beiqi, DAI Yue, WEI Xiaoqing, LU Pei. Clinical roles of SAA and CRP in pathological staging and metastasis of gastrointestinal cancer [J]. Laboratory Medicine, 2022, 37(1): 51-55.
[11]	LIU Jinyan, ZHAO Juntao, XIANG Mingjie. Mechanism and application of serum amyloid A in clinical diseases [J]. Laboratory Medicine, 2021, 36(7): 756-760.
[12]	HUANG Fei, ZHANG Chunyan, GUO Wei, PAN Baishen, WANG Beili. Status and problems of SARS-CoV-2 nucleic acid detection [J]. Laboratory Medicine, 2021, 36(5): 554-559.
[13]	HU Senan, TAN Junfeng, PENG Chang, AI Honghong, LI Dan. Role of blood glucose variability in the prognosis of severe corona virus disease 2019 patients [J]. Laboratory Medicine, 2021, 36(4): 400-403.
[14]	WANG Qian, ZHU Shiyao, LU Di, ZHU Kun, WU Jiong, QUAN Jiali. Arteriosclerotic cardiovascular disease risk markers research progress [J]. Laboratory Medicine, 2021, 36(4): 447-452.
[15]	WANG Bin. Correlation between neutrophil-to-lymphocyte ratio and short-term poor prognosis in patients with corona virus disease 2019 [J]. Laboratory Medicine, 2021, 36(3): 275-280.